PRO-话题@MedSci

#PRO#

800篇内容 | 2597人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1602147, encodeId=e72e160214e5a, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, objectTitle=EASL大会：Promethera干细胞疗法HepaStem在2a临床显示出对急性肝衰竭治疗的安全有效性, objectType=article, longId=164365, objectId=dbfc16436511, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbfc16436511, replyNumber=0, likeNumber=13, createdTime=2019-04-17, rootId=0, userName=sunylz, userId=a60b18898917, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbfc16436511, moduleTitle=EASL大会：Promethera干细胞疗法HepaStem在2a临床显示出对急性肝衰竭治疗的安全有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbfc16436511)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602146, encodeId=1735160214625, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, objectTitle=J Endod：一种全新根管内封药2-hydroxyisocaproic Acid的细胞毒性和基因毒性分析：一项体外研究, objectType=article, longId=164289, objectId=d8ca16428935, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8ca16428935, replyNumber=0, likeNumber=0, createdTime=2019-04-16, rootId=0, userName=sunylz, userId=a60b18898917, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8ca16428935, moduleTitle=J Endod：一种全新根管内封药2-hydroxyisocaproic Acid的细胞毒性和基因毒性分析：一项体外研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8ca16428935)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602145, encodeId=3a091602145c2, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, objectTitle=2019年美国临床内分泌学家协会（AACE）大会：Teprotumumab治疗甲状腺眼病的III期试验结果, objectType=article, longId=164221, objectId=3dc6164221e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3dc6164221e6, replyNumber=0, likeNumber=15, createdTime=2019-04-15, rootId=0, userName=sunylz, userId=a60b18898917, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3dc6164221e6, moduleTitle=2019年美国临床内分泌学家协会（AACE）大会：Teprotumumab治疗甲状腺眼病的III期试验结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3dc6164221e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602144, encodeId=9d861602144a9, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, objectTitle=Heart：射血分数保留vs.射血分数降低心衰患者的预后和NT-proBNP, objectType=article, longId=164191, objectId=79f0164191a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79f0164191a6, replyNumber=0, likeNumber=58, createdTime=2019-04-15, rootId=0, userName=sunylz, userId=a60b18898917, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79f0164191a6, moduleTitle=Heart：射血分数保留vs.射血分数降低心衰患者的预后和NT-proBNP, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79f0164191a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602143, encodeId=9f4116021436c, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, objectTitle=Prostate：未经激素治疗前列腺癌中tSTAT3、pSTAT3 727和pSTAT3 705的表达研究, objectType=article, longId=163774, objectId=1027163e7485, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1027163e7485, replyNumber=0, likeNumber=63, createdTime=2019-04-09, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1027163e7485, moduleTitle=Prostate：未经激素治疗前列腺癌中tSTAT3、pSTAT3 727和pSTAT3 705的表达研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1027163e7485)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602142, encodeId=e53116021428e, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, objectTitle=Prostate Cancer P D：前列腺癌SLCO基因表达与格林森等级和雄激素阻断治疗后变化相关性分析, objectType=article, longId=163635, objectId=f0611636357e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0611636357e, replyNumber=0, likeNumber=78, createdTime=2019-04-06, rootId=0, userName=sunylz, userId=a60b18898917, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0611636357e, moduleTitle=Prostate Cancer P D：前列腺癌SLCO基因表达与格林森等级和雄激素阻断治疗后变化相关性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0611636357e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602141, encodeId=e1e2160214194, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, objectTitle=Lancet：标准化儿科结肠炎治疗反应的临床和生物学预测因子(PROTECT):一项多中心初始队列研究, objectType=article, longId=163542, objectId=28dc163542c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28dc163542c9, replyNumber=0, likeNumber=58, createdTime=2019-04-05, rootId=0, userName=sunylz, userId=a60b18898917, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28dc163542c9, moduleTitle=Lancet：标准化儿科结肠炎治疗反应的临床和生物学预测因子(PROTECT):一项多中心初始队列研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28dc163542c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602140, encodeId=6365160214071, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, objectTitle=PLos One：NT-proBNP预测慢性心衰患者两年预后的价值, objectType=article, longId=163292, objectId=a6cc163292f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6cc163292f1, replyNumber=0, likeNumber=0, createdTime=2019-04-01, rootId=0, userName=sunylz, userId=a60b18898917, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6cc163292f1, moduleTitle=PLos One：NT-proBNP预测慢性心衰患者两年预后的价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6cc163292f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602139, encodeId=9bb8160213954, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, objectTitle=J Endod：Micro-CT观察XP-endo Shaper, Reciproc Blue和ProTaper Universal NiTi对牙本质隐裂形成的, objectType=article, longId=163267, objectId=5cca16326e31, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5cca16326e31, replyNumber=0, likeNumber=122, createdTime=2019-03-31, rootId=0, userName=sunylz, userId=a60b18898917, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5cca16326e31, moduleTitle=J Endod：Micro-CT观察XP-endo Shaper, Reciproc Blue和ProTaper Universal NiTi对牙本质隐裂形成的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5cca16326e31)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602138, encodeId=8a4f160213852, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, objectTitle=JAHA：NT-proBNP与房颤发生风险种族差异相关, objectType=article, longId=163082, objectId=b11e16308270, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b11e16308270, replyNumber=0, likeNumber=76, createdTime=2019-03-29, rootId=0, userName=sunylz, userId=a60b18898917, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b11e16308270, moduleTitle=JAHA：NT-proBNP与房颤发生风险种族差异相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b11e16308270)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602137, encodeId=ecb3160213e4d, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, objectTitle=Nature:针对前列腺癌的PROTACs已进入临床试验！或将开启蛋白靶向降解治疗癌症新篇章！, objectType=article, longId=163067, objectId=e00716306e43, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e00716306e43, replyNumber=0, likeNumber=73, createdTime=2019-03-28, rootId=0, userName=sunylz, userId=a60b18898917, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e00716306e43, moduleTitle=Nature:针对前列腺癌的PROTACs已进入临床试验！或将开启蛋白靶向降解治疗癌症新篇章！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e00716306e43)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602136, encodeId=8264160213660, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, objectTitle=Mayo Clin Proc：适度的肌肉量能降低糖尿病风险？, objectType=article, longId=162842, objectId=0549162842ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0549162842ca, replyNumber=0, likeNumber=0, createdTime=2019-03-25, rootId=0, userName=sunylz, userId=a60b18898917, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0549162842ca, moduleTitle=Mayo Clin Proc：适度的肌肉量能降低糖尿病风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0549162842ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602135, encodeId=1a9f1602135c6, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, objectTitle=Prostate Cancer P D：SPINK1表达在非裔美国人前列腺中富集并且与术后免疫浸润或者肿瘤结果无关, objectType=article, longId=162799, objectId=0967162e9971, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0967162e9971, replyNumber=0, likeNumber=61, createdTime=2019-03-25, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0967162e9971, moduleTitle=Prostate Cancer P D：SPINK1表达在非裔美国人前列腺中富集并且与术后免疫浸润或者肿瘤结果无关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0967162e9971)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602134, encodeId=c93a160213411, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, objectTitle=Prostate Cancer P D：MRI-US融合前列腺活检学习曲线鉴定分析, objectType=article, longId=162606, objectId=9c54162606a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c54162606a4, replyNumber=0, likeNumber=55, createdTime=2019-03-20, rootId=0, userName=sunylz, userId=a60b18898917, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c54162606a4, moduleTitle=Prostate Cancer P D：MRI-US融合前列腺活检学习曲线鉴定分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c54162606a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602133, encodeId=4cf9160213387, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, objectTitle=Int J Prosthodont：不同材料制备的修复体的负荷能力, objectType=article, longId=162479, objectId=cbb31624e9d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cbb31624e9d9, replyNumber=0, likeNumber=52, createdTime=2019-03-18, rootId=0, userName=sunylz, userId=a60b18898917, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cbb31624e9d9, moduleTitle=Int J Prosthodont：不同材料制备的修复体的负荷能力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cbb31624e9d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602132, encodeId=947f1602132c5, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, objectTitle=Prostate Cancer P D：良性前列腺增生中摘除术与切除术效果和安全性评估, objectType=article, longId=162421, objectId=888416242105, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=888416242105, replyNumber=0, likeNumber=72, createdTime=2019-03-17, rootId=0, userName=sunylz, userId=a60b18898917, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=888416242105, moduleTitle=Prostate Cancer P D：良性前列腺增生中摘除术与切除术效果和安全性评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=888416242105)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602131, encodeId=01c11602131ca, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, objectTitle=Prostate Cancer P D：MEK-ERK信号是转移去势抵抗性前列腺癌的治疗靶标, objectType=article, longId=162284, objectId=205b162284e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=205b162284e8, replyNumber=0, likeNumber=99, createdTime=2019-03-15, rootId=0, userName=sunylz, userId=a60b18898917, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=205b162284e8, moduleTitle=Prostate Cancer P D：MEK-ERK信号是转移去势抵抗性前列腺癌的治疗靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=205b162284e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602130, encodeId=2aaa1602130d7, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, objectTitle=MYR Pharma的NTCP受体抑制剂Bulevirtide治疗慢性丁型肝炎感染被授予Promising Innovative Medicine 称号, objectType=article, longId=161805, objectId=b36616180596, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b36616180596, replyNumber=0, likeNumber=11, createdTime=2019-03-08, rootId=0, userName=sunylz, userId=a60b18898917, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b36616180596, moduleTitle=MYR Pharma的NTCP受体抑制剂Bulevirtide治疗慢性丁型肝炎感染被授予Promising Innovative Medicine 称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b36616180596)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602129, encodeId=d67b16021297b, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, objectTitle=Procarta获得150万欧元资助用于新型抗生素的研发以抗击抗菌素耐药性, objectType=article, longId=161793, objectId=206b161e93a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=206b161e93a1, replyNumber=0, likeNumber=115, createdTime=2019-03-08, rootId=0, userName=sunylz, userId=a60b18898917, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=206b161e93a1, moduleTitle=Procarta获得150万欧元资助用于新型抗生素的研发以抗击抗菌素耐药性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=206b161e93a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1602128, encodeId=99031602128aa, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, objectTitle=JCO：PROSTVAC在转移性去势抵抗性前列腺癌中的III期试验, objectType=article, longId=161545, objectId=3b1a161545a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b1a161545a9, replyNumber=0, likeNumber=67, createdTime=2019-03-04, rootId=0, userName=sunylz, userId=a60b18898917, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b1a161545a9, moduleTitle=JCO：PROSTVAC在转移性去势抵抗性前列腺癌中的III期试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b1a161545a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

PRO

2020-05-29

sunylz (审核中...)

前往app查看评论内容

#PRO#

EASL大会：Promethera干细胞疗法HepaStem在2a临床显示出对急性肝衰竭治疗的安全有效性

2019-04-17

sunylz (审核中...)

前往app查看评论内容

#PRO#

J Endod：一种全新根管内封药2-hydroxyisocaproic Acid的细胞毒性和基因毒性分析：一项体外研究

2019-04-16

sunylz (审核中...)

前往app查看评论内容

#PRO#

2019年美国临床内分泌学家协会（AACE）大会：Teprotumumab治疗甲状腺眼病的III期试验结果

2019-04-15

sunylz (审核中...)

前往app查看评论内容

#PRO#

Heart：射血分数保留vs.射血分数降低心衰患者的预后和NT-proBNP

2019-04-15

zhouqu_8 (审核中...)

前往app查看评论内容

#PRO#

Prostate：未经激素治疗前列腺癌中tSTAT3、pSTAT3 727和pSTAT3 705的表达研究

2019-04-09

sunylz (审核中...)

前往app查看评论内容

#PRO#

Prostate Cancer P D：前列腺癌SLCO基因表达与格林森等级和雄激素阻断治疗后变化相关性分析

2019-04-06

sunylz (审核中...)

前往app查看评论内容

#PRO#

Lancet：标准化儿科结肠炎治疗反应的临床和生物学预测因子(PROTECT):一项多中心初始队列研究

2019-04-05

sunylz (审核中...)

前往app查看评论内容

#PRO#

PLos One：NT-proBNP预测慢性心衰患者两年预后的价值

2019-04-01

sunylz (审核中...)

前往app查看评论内容

#PRO#

J Endod：Micro-CT观察XP-endo Shaper, Reciproc Blue和ProTaper Universal NiTi对牙本质隐裂形成的

2019-03-31

sunylz (审核中...)

前往app查看评论内容

#PRO#

JAHA：NT-proBNP与房颤发生风险种族差异相关

2019-03-29

sunylz (审核中...)

前往app查看评论内容

#PRO#

Nature:针对前列腺癌的PROTACs已进入临床试验！或将开启蛋白靶向降解治疗癌症新篇章！

2019-03-28

sunylz (审核中...)

前往app查看评论内容

#PRO#

Mayo Clin Proc：适度的肌肉量能降低糖尿病风险？

2019-03-25

zhaojie88 (审核中...)

前往app查看评论内容

#PRO#

Prostate Cancer P D：SPINK1表达在非裔美国人前列腺中富集并且与术后免疫浸润或者肿瘤结果无关

2019-03-25

sunylz (审核中...)

前往app查看评论内容

#PRO#

Prostate Cancer P D：MRI-US融合前列腺活检学习曲线鉴定分析

2019-03-20

sunylz (审核中...)

前往app查看评论内容

#PRO#

Int J Prosthodont：不同材料制备的修复体的负荷能力

2019-03-18

sunylz (审核中...)

前往app查看评论内容

#PRO#

Prostate Cancer P D：良性前列腺增生中摘除术与切除术效果和安全性评估

2019-03-17

sunylz (审核中...)

前往app查看评论内容

#PRO#

Prostate Cancer P D：MEK-ERK信号是转移去势抵抗性前列腺癌的治疗靶标

2019-03-15

sunylz (审核中...)

前往app查看评论内容

#PRO#

MYR Pharma的NTCP受体抑制剂Bulevirtide治疗慢性丁型肝炎感染被授予Promising Innovative Medicine 称号

2019-03-08

sunylz (审核中...)

前往app查看评论内容

#PRO#

Procarta获得150万欧元资助用于新型抗生素的研发以抗击抗菌素耐药性

2019-03-08

sunylz (审核中...)

前往app查看评论内容

#PRO#

JCO：PROSTVAC在转移性去势抵抗性前列腺癌中的III期试验

2019-03-04

科室
- - 订阅+
  - 更多科室
工具
服务